K Bakken1, A S Landheim, P Vaglum. 1. Centre for Addiction Issues, Department for Substance Abuse, Sykehuset Innlandet HF Sanderud, Postboks 68, 2312 Ottestad, Norway. kjell.bakken@sykehuset-innlandet.no
Abstract
AIMS: (1) To identify clinically important differences between patients with and without social anxiety disorder (SAD) among alcohol-dependent and poly-substance-dependent patients. (2) To explore if primary SAD is a predictor of alcohol-dependency or poly-substance dependency when controlling for other Axes I and II disorders. METHODS: A consecutive sample of in- and outpatient alcohol-dependent (N = 146) and poly-substance-dependent patients (N = 114) from public treatment programmes in two catchment areas was assessed by personal interview, the Composite International Diagnostic Interview and the Millon Clinical Multiaxial Inventory. RESULTS: The frequency of current SAD was 42%; SAD was significantly more frequent among poly-substance-dependent patients (51%) than among alcohol-dependent patients (34%). Patients with SAD do not represent a distinct clinical subgroup, but the occurrence of SAD is combined with the occurrence of other anxiety disorders, affective disorders and personality disorders in both substance groups. The analysis showed a trend towards primary SAD as a predictor for developing poly-substance dependency. CONCLUSIONS: Patients with SAD in both substance groups exhibited more comorbid Axis I and II disorders. They may need specific psychiatric treatment for such disorders in addition to treatment for SAD. Treatment of primary SAD could be a target for preventing poly-substance dependency in young populations.
AIMS: (1) To identify clinically important differences between patients with and without social anxiety disorder (SAD) among alcohol-dependent and poly-substance-dependent patients. (2) To explore if primary SAD is a predictor of alcohol-dependency or poly-substance dependency when controlling for other Axes I and II disorders. METHODS: A consecutive sample of in- and outpatientalcohol-dependent (N = 146) and poly-substance-dependent patients (N = 114) from public treatment programmes in two catchment areas was assessed by personal interview, the Composite International Diagnostic Interview and the Millon Clinical Multiaxial Inventory. RESULTS: The frequency of current SAD was 42%; SAD was significantly more frequent among poly-substance-dependent patients (51%) than among alcohol-dependent patients (34%). Patients with SAD do not represent a distinct clinical subgroup, but the occurrence of SAD is combined with the occurrence of other anxiety disorders, affective disorders and personality disorders in both substance groups. The analysis showed a trend towards primary SAD as a predictor for developing poly-substance dependency. CONCLUSIONS:Patients with SAD in both substance groups exhibited more comorbid Axis I and II disorders. They may need specific psychiatric treatment for such disorders in addition to treatment for SAD. Treatment of primary SAD could be a target for preventing poly-substance dependency in young populations.
Authors: Kate Wolitzky-Taylor; Lily A Brown; Peter Roy-Byrne; Cathy Sherbourne; Murray B Stein; Greer Sullivan; Alexander Bystritsky; Michelle G Craske Journal: J Anxiety Disord Date: 2015-01-08
Authors: Michael P Bogenschutz; Snehal Bhatt; Juliane Bohan; Bellelizabeth Foster; Paul Romo; Claire E Wilcox; J Scott Tonigan Journal: Am J Drug Alcohol Abuse Date: 2016-05-16 Impact factor: 3.829
Authors: Sarah W Book; Suzanne E Thomas; Jared P Dempsey; Patrick K Randall; Carrie L Randall Journal: Addict Behav Date: 2009-01-07 Impact factor: 3.913
Authors: Henning Pettersen; Anne Landheim; Ivar Skeie; Stian Biong; Morten Brodahl; Victoria Benson; Larry Davidson Journal: Subst Abuse Date: 2018-02-07
Authors: Andrew J Baillie; Claudia Sannibale; Lexine A Stapinski; Maree Teesson; Ronald M Rapee; Paul S Haber Journal: BMC Psychiatry Date: 2013-07-30 Impact factor: 3.630
Authors: Petra K Staiger; Michael Kyrios; James S Williams; Nicolas Kambouropoulos; Alexandra Howard; Stefan Gruenert Journal: BMC Psychiatry Date: 2014-02-17 Impact factor: 3.630